These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
624 related articles for article (PubMed ID: 27774831)
21. Encapsulated peritoneal sclerosis: a single center, retrospective analysis of clinical manifestations, risk factors and prognosis. Koc Y; Basturk T; Sakaci T; Caglayan FB; Hasbal NB; Ahbap E; Sevinc M; Sinangil A; Ucar ZA; Nazif P; Islam M; Unsal A Minerva Urol Nefrol; 2018 Aug; 70(4):429-436. PubMed ID: 29478308 [TBL] [Abstract][Full Text] [Related]
22. Encapsulating peritoneal sclerosis in the era of a multi-disciplinary approach based on biocompatible solutions: the NEXT-PD study. Nakayama M; Miyazaki M; Honda K; Kasai K; Tomo T; Nakamoto H; Kawanishi H Perit Dial Int; 2014; 34(7):766-74. PubMed ID: 24497585 [TBL] [Abstract][Full Text] [Related]
23. Time Is Not Always the Matter: An Instance of Encapsulating Peritoneal Sclerosis Developing in a Patient on Peritoneal Dialysis for a Short Term. De Oleo RR; Villanueva H; Lwin L; Katikaneni M; Yoo J Adv Perit Dial; 2016; 32():19-21. PubMed ID: 28988585 [TBL] [Abstract][Full Text] [Related]
24. Outcome and complications in peritoneal dialysis patients: a five-year single center experience. Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621 [TBL] [Abstract][Full Text] [Related]
25. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis--a multicentre study in Japan. Hirahara I; Inoue M; Okuda K; Ando Y; Muto S; Kusano E Nephrol Dial Transplant; 2007 Feb; 22(2):560-7. PubMed ID: 17035369 [TBL] [Abstract][Full Text] [Related]
26. Restoration of peritoneal integrity after withdrawal of peritoneal dialysis: characteristic features of the patients at risk of encapsulating peritoneal sclerosis. Otsuka Y; Nakayama M; Ikeda M; Sherif AM; Yokoyama K; Yamamoto H; Kawaguchi Y Clin Exp Nephrol; 2005 Dec; 9(4):315-319. PubMed ID: 16362159 [TBL] [Abstract][Full Text] [Related]
27. Incidence and outcomes of encapsulating peritoneal sclerosis (EPS) and factors associated with severe EPS. Tseng CC; Chen JB; Wang IK; Liao SC; Cheng BC; Wu AB; Chang YT; Hung SY; Huang CC PLoS One; 2018; 13(1):e0190079. PubMed ID: 29293548 [TBL] [Abstract][Full Text] [Related]
28. Significant Decreasing Incidence of Encapsulating Peritoneal Sclerosis in the Dutch Population of Peritoneal Dialysis Patients. Betjes MG; Habib SM; Boeschoten EW; Hemke AC; Struijk DG; Westerhuis R; Abrahams AC; Korte MR Perit Dial Int; 2017; 37(2):230-234. PubMed ID: 28360369 [TBL] [Abstract][Full Text] [Related]
29. The peritoneal sieving of sodium: a simple and powerful test to rule out the onset of encapsulating peritoneal sclerosis in patients undergoing peritoneal dialysis. La Milia V; Longhi S; Sironi E; Pontoriero G J Nephrol; 2018 Feb; 31(1):137-145. PubMed ID: 28012100 [TBL] [Abstract][Full Text] [Related]
30. Encapsulating peritoneal sclerosis: case series from a university center. Hong KD; Bae JH; Jang YJ; Jung HY; Cho JH; Choi JY; Kim CD; Kim YL; Park SH Korean J Intern Med; 2013 Sep; 28(5):587-93. PubMed ID: 24009455 [TBL] [Abstract][Full Text] [Related]
31. Incidence of encapsulating peritoneal sclerosis: a single-center experience with long-term peritoneal dialysis in the United States. Gayomali C; Hussein U; Cameron SF; Protopapas Z; Finkelstein FO Perit Dial Int; 2011; 31(3):279-86. PubMed ID: 21555415 [TBL] [Abstract][Full Text] [Related]
32. The role of peritoneal lavage and the prognostic significance of mesothelial cell area in preventing encapsulating peritoneal sclerosis. Yamamoto T; Nagasue K; Okuno S; Yamakawa T Perit Dial Int; 2010; 30(3):343-52. PubMed ID: 20338969 [TBL] [Abstract][Full Text] [Related]
34. Encapsulating peritoneal sclerosis: what have we learned? Goodlad C; Brown EA Semin Nephrol; 2011 Mar; 31(2):183-98. PubMed ID: 21439432 [TBL] [Abstract][Full Text] [Related]
35. Incidence of encapsulating peritoneal sclerosis at a single U.S. university center. Bansal S; Sheth H; Siddiqui N; Bender FH; Johnston JR; Piraino B Adv Perit Dial; 2010; 26():75-81. PubMed ID: 21348385 [TBL] [Abstract][Full Text] [Related]
36. Peritoneal inflammation precedes encapsulating peritoneal sclerosis: results from the GLOBAL Fluid Study. Lambie MR; Chess J; Summers AM; Williams PF; Topley N; Davies SJ; Nephrol Dial Transplant; 2016 Mar; 31(3):480-6. PubMed ID: 26908833 [TBL] [Abstract][Full Text] [Related]
37. Lower mortality and inflammation from post-transplantation encapsulating peritoneal sclerosis compared to the classical form. Habib SM; Korte MR; Betjes MG Am J Nephrol; 2013; 37(3):223-30. PubMed ID: 23467015 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for adverse outcomes after peritonitis-related technique failure. Moon SJ; Han SH; Kim DK; Lee JE; Kim BS; Kang SW; Choi KH; Lee HY; Han DS Perit Dial Int; 2008; 28(4):352-60. PubMed ID: 18556377 [TBL] [Abstract][Full Text] [Related]
40. Risk factors and clinical outcomes of encapsulating peritoneal sclerosis: A case-control study from China. Lu M; Ye H; Chen D; Yi C; Lin J; Mao H; Yang X; Yu X; Chen W Perit Dial Int; 2022 Sep; 42(5):505-512. PubMed ID: 34259109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]